PTGS2 and rheumatoid arthritis: In addition, 16 common target genes of FDA approved anti-RA drugs appear in the disease influenced subnetwork and the subnetworks regulated by moderate dose WGYK, dexamethasone, and Qing Peng ointment, including the most important target gene PTGS2 for nonsteroidal anti-inflammatory agents and TNF for biotech agents.